ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1570 • 2018 ACR/ARHP Annual Meeting

    Clinical Utility of a Second Minor Salivary Gland Biopsy in Patients with Suspected Sjögren’s Syndrome: A Retrospective Cohort Study

    Thibaud Depinoy1, Valérie Devauchelle-Pensec2, Sandrine Jousse-Joulin3, Thierry Marhadour1, Dewi Guellec3, Pascale Marcorelles1, Jacques-Olivier Pers2, Alain Saraux3 and Divi Cornec4, 1CHU Brest, Brest, France, 2U1227, Université de Brest, Inserm, Labex IGO, CHU de Brest, Brest, France, 3Rheumatology, CHU Brest, Brest, France, 4Rheumatology and UMR1227, Lymphocytes B et Autoimmunité, CHU Brest, Brest, France

    Background/Purpose: To determine whether the repetition of minor salivary gland biopsy (MSGB) has a clinical diagnostic utility in patients with suspicion of primary Sjögren’s syndrome…
  • Abstract Number: 1571 • 2018 ACR/ARHP Annual Meeting

    RNA Sequencing Detection of Gene Dysregulation in Epithelial Cells Sorted from Salivary Gland Tissue Reveals Interesting Pathways Involved in Primary Sjögren’s Syndrome Pathophysiology

    Elodie Rivière1,2, Nicolas Tchitchek1, Gaetane Nocturne1,3, Juliette Pascaud1, Alexandre Virone1, Saida Boudaoud1, Alice Thai4, Normand Allaire4, Bernd Jagla5, Michael Mingueneau4 and Xavier Mariette1,3, 1Immunology of viral Infections and Autoimmune Diseases, IDMIT, CEA - Université Paris Sud - INSERM U1184, Le Kremlin Bicêtre & Fontenay aux Roses, France, 2Arthritis Fondation Courtin, Paris, France, 3Rheumatology, Université Paris Sud, Le Kremlin Bicêtre, France, 4Immunology Research, Biogen, Cambridge, MA, 5Biomarker Discovery Platform UTechS CB, Hub de Bioinformatique et biostatistique C3IB, Institut Pasteur, Paris, France

    Background/Purpose: Primary Sjögren's syndrome (pSS) is a chronic autoimmune disorder characterized by lymphocytic infiltrates and destruction of the salivary glands. Several lines of evidence support…
  • Abstract Number: 1572 • 2018 ACR/ARHP Annual Meeting

    Salivary Flow Rates and Oral Health Related Quality of Life Are Associated with Ultrasonographic Scoring of the Major Salivary Glands in Sjogren Syndrome

    Yasemin Yalçınkaya1, Gonca Mumcu2, Filiz Ture Ozdemir3, Zeynep Erturk1, Ali Ugur Unal1, Pamir Atagunduz4, Haner Direskeneli5 and Nevsun Inanc6,7, 1Department of Internal Medicine, Division of Rheumatology, Marmara University, Istanbul, Turkey, 2Department of Health Management, Marmara University, Faculty of Health Sciences, Istanbul, Turkey, 3Marmara University, School of Medicine, Department of Immunology, Istanbul, Turkey, 4Department Internal Medicine, Division of Rheumatology, Marmara University,, Istanbul, Turkey, 5Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, 6Marmara University, Istanbul, Turkey, 7Departement of İnternal Medicine, Division of Rheumatology, Marmara University, Istanbul, Turkey

    Background/Purpose:  Ultrasonography (USG) of major salivary glands (SG-USG) as a non-invasive method is widely used to evaluate salivary gland involvement in Sjogren’s syndrome (SjS). Since…
  • Abstract Number: 1573 • 2018 ACR/ARHP Annual Meeting

    Salivary Dysbiosis Correlates with Clinical Status of Anti-Ro Positive Mothers of Children with Neonatal Lupus

    Robert M. Clancy1, Carl Langefeld2, Hannah C. Ainsworth3, Martin Blaser4, Peter M. Izmirly5, Corey Lacher1, Miranda C Marion6, Mala Masson1, Gregg Silverman7 and Jill P. Buyon1, 1NYU School of Medicine, New York, NY, 2Wake Forest School of Medicine, Winston-Salem, NC, 3Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 4Director of the NYU Human Microbiome Program, NYU School of Medicine, New York, NY, 5Rheumatology, NYU School of Medicine, New York, NY, 6Biostatistical Sciences and Center for Public Health Genomics, Wake Forest School of Medicine, Winston-Salem, NC, 7Dept of Medicine, NYU School of Medicine, New York, NY

    Background/Purpose: Neonatal lupus is linked to the presence of circulating anti-Ro antibodies in the mother. These antibodies are present in asymptomatic individuals, who in a…
  • Abstract Number: 1574 • 2018 ACR/ARHP Annual Meeting

    Autoantibodies Present in Saliva from Sjogren’s Syndrome and Non-Sjogren’s Sicca Patients Are Not Detectible in Serum

    Kristi A. Koelsch1,2,3, Joshua Cavett3,4, Kenneth Smith3, Jacen Maier-Moore5, Astrid Rasmussen3, David M. Lewis6, Lida Radfar7, Biji T. Kurien2,4,8, Judith A. James3,9, Kathy L. Sivils10, A. Darise Farris11 and R. Hal Scofield2,11,12, 1Section of Endocrinology and Diabetes, University of Oklahoma Health Sciences Center, Okalahoma City, OK, 2U.S. Department of Veterans Affairs Medical Center, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 4College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5Clinical Laboratory Science, University of Texas at El Paso, El Paso, TX, 6Department of Oral and Maxillofacial Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 7Department of Oral Diagnosis and Radiology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 8Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 9University of Oklahoma Health Sciences Center, Oklahoma City, OK, 10Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma, OK, 11Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 12Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK

    Background/Purpose: There is evidence for B cell involvement in the pathogenesis of Sjögren’s syndrome by the presence of autoantigen-specific B cells. Autoantibodies toward Ro/SSA and…
  • Abstract Number: 1575 • 2018 ACR/ARHP Annual Meeting

    The Association between Salivary Gland Ultrasonography and Clinical Manifestation in Patients with Early Primary Sjögren’s Syndrome

    Yen-Fu Chen1 and Yao-Fan Fang2, 1Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 2Chang-Gung Memorial Hospital, Taoyuan city, Taiwan

    Background/Purpose: To investigate the clinical manifestations in patients with early primary Sjögren¡¦s syndrome based on different severity score under salivary gland ultrasonography.Methods: We enrolled 44…
  • Abstract Number: 1576 • 2018 ACR/ARHP Annual Meeting

    Soluble Semaphorin 4D/CD100 Is Increased in the Saliva of Sjögren’s Syndrome

    Shin Eui Kang1, Jeong Seok Lee2, Ji Soo Park1, Ji Hye Lee2, Jeong Yeon Kim1, Hyun Jung Yoo2, Yun Jong Lee3, Eun Young Lee4, Eun Bong Lee2 and Yeong Wook Song1,5, 1Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea, Republic of (South), 2Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South), 3Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Korea, Republic of (South), 4Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Republic of (South), 5Rheumatology, Seoul National University Hospital, Seoul, Korea, Republic of (South)

    Background/Purpose: Sjögren’s syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration in exocrine organs with dry mouth and dry eyes. Semaphorin 4D (SEMA4D) /…
  • Abstract Number: 1577 • 2018 ACR/ARHP Annual Meeting

    Soluble Siglec-5 Is a Novel Salivary Biomarker for Primary Sjogren’s Syndrome

    Jennifer Lee1, Hong-Ki Min2, Ji-Won Kim3, Seung-Ki Kwok4 and Sung-Hwan Park5, 1Rheumatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), 2Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), 3Medicine, Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), 4Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul., Seoul, Korea, Republic of (South), 5Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

    Background/Purpose: Despite advances in the understanding of the pathogenesis, disease-specific biomarkers have not been included in the classification criteria for Primary Sjogren's syndrome (pSS). Based…
  • Abstract Number: 1578 • 2018 ACR/ARHP Annual Meeting

    Exercise Increases Aerobic Capacity in Primary Sjögren´s Syndrome: A Randomized Controlled Trial

    Ana Beatriz Andreo Garcia, MD1, Virginia Fernandes Moça Trevisani2, Luciana Dardin3 and Paulo Alexandre Minali4, 1Evidence-based Health, UNIFESP, São Paulo, Brazil, São Paulo, Brazil, 2UNIFESP, Sao Paulo, Brazil, San Paulo, Brazil, 3Emergency Medicine and Evidence-Based Medicine Department, UNIFESP, São Paulo Brazil, SÃO PAULO, Brazil, 4UNIFESP, São Paulo, Brazil, São Paulo, Brazil

    Background/Purpose: Recent studies have shown increased cardiovascular risk in patients with primary Sjögren's syndrome (pSS). As physical exercise is one of the pillars in primary…
  • Abstract Number: 1579 • 2018 ACR/ARHP Annual Meeting

    Sjögren’s Syndrome Is Associated with Reduced Sex Hormone Exposure: A Case-Control Study

    Sara S. McCoy1, Emmanuel Sampene2 and Alan N. Baer3, 1Department of Medicine, Rheumatology Division, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2Biostatistics, University of Wisconsin School of Medicine and Public Health, Madison, WI, 3Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Sjögren’s Syndrome (SS) is an autoimmune disease with female predominance and frequent perimenopausal onset, indicating a potential pathogenic role for sex hormones.  The goal…
  • Abstract Number: 1580 • 2018 ACR/ARHP Annual Meeting

    Persistent Serological Activity in Primary Sjögren’s Syndrome

    Jorge Lopez-Morales, Daniel Cortes-Muñoz and Gabriela Hernandez-Molina, Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición SZ, Mexico City, Mexico

    Background/Purpose: To assess presence of persistent serological activity and its association with clinical outcomes in a cohort of patients with primary Sjögren’s syndrome (pSS). Methods:…
  • Abstract Number: 1581 • 2018 ACR/ARHP Annual Meeting

    Lack of Specificity in Testing for Murine Tissue Specific Autoantibodies for the Diagnosis of Sjogren’s Syndrome

    Frederick B Vivino1, Michael D. George2, Chadwick Johr3, Nora Sandorfi4, Vatinee Bunya5, Giacomina Massaro-Giordano5, Andrew Diederich6, Brandon Eilberg6, Lakshmanan Suresh7 and Long Shen7, 1Rheumatolgy Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA, 2Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, 3University of Pennsylvania, Philadelphia, PA, 4Rheumatology, University of Pennsylvania, Philadelphia, PA, 5Ophthalmology, University of Pennsylvania, Philadelphia, PA, 6Orthopedic Surgery, University of Pennsylvania, Philadelphia, PA, 7Trinity Biotech, Inc., Buffalo, NY

    Background/Purpose: A group of murine parotid tissue specific autoantibodies (TSAs) which includes anti-SP1 (salivary protein 1), anti-PSP (parotid secretory protein) and anti-CA6 (carbonic anhydrase) are…
  • Abstract Number: 1582 • 2018 ACR/ARHP Annual Meeting

    Clinical Correlations and Expression Pattern of the Autoimmunity Susceptibility Factor Diora-1 in Primary Sjögren’s Syndrome

    Lauro Meneghel1, Lara Aqrawi1,2,3, Lara Mentlein1, Albin Björk1, Gudny Ella Thorlacius1, Margarita Ivanchenko1, Jorge Ramírez1, Kathrine Skarstein2,4, Marika Kvarnström1, Susanna Brauner1, Alexander Espinosa1 and Marie Wahren-Herlenius1, 1Unit of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 2The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway, Bergen, Norway, 3Department of Oral Surgery and Oral Medicine, Institute of Clinical Odontology, University of Oslo, Oslo, Norway, Oslo, Norway, 4Department of Pathology, Haukeland University Hospital, Bergen, Bergen, Norway

    Background/Purpose: Genome-wide association studies of multiple autoimmune diseases, including primary Sjögren’s syndrome (pSS), systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) have revealed an association…
  • Abstract Number: 1583 • 2018 ACR/ARHP Annual Meeting

    Low-Dose IL-2 Promotes the Proliferation of Peripheral Regulatory T Cells in Primary Sjogren’s Syndrome to Restore Its Balances with Pro-Inflammatory Lymphocytes

    Miao Miao1, Zhenye Hao1, Yingying Guo1, Xiaoying Zhang1, Sheng-Xiao Zhang1, Jing Luo2, Jinfang Zhao3, Chong Gao4 and Xiao-Feng Li5, 1The Second Hospital of Shanxi Medical University, Taiyuan, China, 2the Second Hospital of Shanxi Medical University, Taiyuan, China, 3The Shanxi Medical University, Taiyuan, China, 4Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, Cambridge, MA, 5Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, China

    Background/Purpose: To investigate the effect of low-dose IL-2 on the balance of Treg with Teff and other pro-inflammatory lymphocytes in peripheral blood of pSS patients.Methods:…
  • Abstract Number: 1584 • 2018 ACR/ARHP Annual Meeting

    Evaluation of the Performance of the 2016 American College of Rheumatology-European League Against Rheumatism (Acr-Eular) Classification Criteria for Primary Sjogren`S Syndrome in Different Centers of Argentina

    Hugo Najera1, Marta Mamani2, Anastasia Secco1, Fernando Melo3, Cristian Troitiño4, Felix Romanini Sr.2, Emmanuel Guerra2, Antonio Catalan Pellet5, Silvia Beatriz Papasidero6, Rodrigo Aguila Maldonado7, Mercedes Garcia7, Mariano Rivero8, Juan Carlos Barreira9, ivan remolina10, A. perdomo11, quevedo mayorga10, M.J. santacruz12 and j demarchi10, 1Rheumatology Section, Hospital Bernardino Rivadavia, CABA, Argentina, 2Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 3Rheumatology Department, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 4Reumatologia, Hospital Bernardino Rivadavia, CAPITAL FEDERAL, Argentina, 5Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 6Rheumatology Section, Hospital General de Agudos Dr. Enrique Tornú, Argentina, Buenos Aires, Argentina, 7Rheumatology, HIGA General San Martin La Plata, La Plata, Argentina, 8Rheumatology, Consultorios Externos Vacarezza,Alberdi,Pcia Buenos Aires, Pcia Buenos Aires, Argentina, 9Rheumatology Unit, Hospital Británico, Buenos Aires, Buenos Aires, Argentina, 10hospital britanico, Buenos Aires, Argentina, 11hospital nuestra señora de la merced, alberti, Argentina, 12hospital tornu, Buenos Aires, Argentina

    Background/Purpose: Primary Sjögren`s Syndrome (pSS) is a multisystemic, autoimmunity disease, characterized mainly by the hypofunction of the salivary and lacrimal glands, however the clinical spectrum…
  • « Previous Page
  • 1
  • …
  • 1289
  • 1290
  • 1291
  • 1292
  • 1293
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology